| Net income | -37.2M |
| Income from discontinued operations, net of taxes | |
| Taxes related to sale of discontinued operations | |
| Gain on deconsolidation of GST, net of taxes | |
| Depreciation | 22.8M |
| Amortization | 19.9M |
| Accretion of debt discount | |
| Deferred income taxes | |
| Stock-based compensation | 4.8M |
| Asbestos liabilities, net of insurance receivables | |
| Accounts and notes receivable | |
| Inventories | 2M |
| Accounts payable | -17.4M |
| Other current assets and liabilities | -4.7M |
| Other non-current assets and liabilities | -16.1M |
| Net cash provided by (used in) operating activities of continuing operations | 7.9M |
| Purchases of property, plant and equipment | -24.6M |
| Divestiture of business | |
| Deconsolidation of GST | |
| Acquisitions, net of cash acquired | -28.5M |
| Other | 3.7M |
| Net cash provided by (used in) investing activities of continuing operations | -52.5M |
| Net repayments of short-term borrowings | |
| Repayments of debt | -192.7M |
| Debt issuance costs | |
| Proceeds from issuance of common stock | |
| Net cash used in financing activities of continuing operations | 67.7M |
| Operating cash flows | |
| Investing cash flows | |
| Net cash provided by discontinued operations | |
| Effect of exchange rate changes on cash and cash equivalents | -11.7M |
| Net increase (decrease) in cash and cash equivalents | 11.4M |
| Cash and cash equivalents at beginning of year | 103.4M |
| Cash and cash equivalents at end of period | 114.8M |
| Interest | 39.7M |
| Income taxes | 26.8M |
| Asbestos-related claims and expenses, net of insurance recoveries | |